| Literature DB >> 32000387 |
Jianan Feng1, Jinyu Yu1, Xueyao Wang2, Yue Wang1, Yang Liu1, Zhonggao Xu1, Weixia Sun1.
Abstract
RATIONALE: IgG4-related disease (IgG4-RD) is a slowly progressing inflammatory disease that can involve multiple organ systems. There is considerable overlap between IgG4-RDs and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Herein, we present an unusual case of IgG4-associated tubulointerstitial nephritis (IgG4-TIN) and ANCA-associated glomerulonephritis (ANCA-GN) co-occurring with C3 glomerulonephritis (C3GN). PATIENT CONCERNS: A 72-year-old male was admitted to hospital because of fever and fatigue. He was diagnosed with elevated serum creatinine and IgG4 levels, and was positive for ANCA. DIAGNOSIS: Initially, the pathology supported a diagnosis of IgG4-TIN and ANCA-GN; however, further examination revealed he also had C3GN.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32000387 PMCID: PMC7004583 DOI: 10.1097/MD.0000000000018857
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
Figure 1Pathological findings in the renal biopsy specimen. (A) Necrotizing crescentic glomerulonephritis (HE 200×). (B) Plasma cell infiltrates in the renal interstitium (HE 400×). (C, D) IgG-positive and IgG4-positive plasma cell infiltrates in the renal intersitium (immunohistochemical staining, 400X). (E) Glomerular immunofluorescence showing diffuse granular mesangial deposition of C3 (400X). (F) Electron microscopy image demonstrating subepithelial intramembranous and mesangial deposits (red arrow).
Figure 2Therapeutic course of methylprednisolone (MP) and cyclophosphamide (CTX). The initial dose of methylprednisolone (delivered orally) was 120 mg/d, which was reduced to 80 mg/d, 60 mg/d, and then 40 mg/d, before finally being finally reduced gradually to maintenance levels. On the tenth day of MP therapy, cyclophosphamide was added. The initial dose of cyclophosphamide was 0.4 g. Fifteen days later,the dose was increased to 0.6 g per month.
Figure 3Clinical course after admission. C-reactive protein (CRP); creatinine (Cr).